Canaccord Genuity Starts Zalicus (ZLCS) at Buy; Synavive: Safer Steroid with Significant Potential in RA

Go back to Canaccord Genuity Starts Zalicus (ZLCS) at Buy; Synavive: Safer Steroid with Significant Potential in RA
ZALICUS (NASDAQ: ZLCS) Delayed: 1.18 --0 (-0%)
Previous Close $1.18    52 Week High $1.74 
Open $17.62    52 Week Low $0.86 
Day High $1.18    P/E N/A 
Day Low $1.18    EPS $-1.70 
Volume 577,304